Draghi, Confindustria and Spallanzani do not snore on Sputnik
All the latest news in Italy on the Russian Sputnik anti Covid vaccine
While waiting for the EMA to fly to Russia to test the Sputnik vaccine, Italy is trying to speed up the production times of the vaccine.
The round table organized by the Italian-Russian Dialogue Forum was held today entitled "Evolution of the pandemic, Russian Sputnik V vaccine, its characteristics and prospects for use".
Here are all the moves of Italy on the Sputnik vaccine.
THE INTENTIONS OF DRAGONS
In recent days, Mario Draghi has opened the adoption of Sputnik in Italy, even if different indications should arrive from Ema and Europe. “European coordination is the first way to look for vaccines. If the EU continues on Sputnik well, otherwise it will proceed in another way. With pragmatism, European coordination must be sought, if it is not possible to maintain it, other ways can be seen ”, said the premier.
DRAGONS LIKE MERKEL
Words that somehow follow the German line: “Germany uses all the vaccines authorized by the EMA. I would prefer a European order. If this does not arrive, which I have no indication of, we would have to take a German route, this would be possible. And we would too, ”said Angela Merkel.
THE ITALIAN-RUSSIAN ROUND TABLE
The round table organized by the Italian-Russian Dialogue Forum was held today, entitled “Evolution of the pandemic, Russian Sputnik V vaccine, its characteristics and prospects for use”.
A round table in which the foundations seem to have been laid for a collaboration that should proceed on the double track: purchase and in-house production.
SPALLANZANI STUDIES EFFECTIVENESS AGAINST VARIATIONS
And in the name of this collaboration the Spallanzani of Rome moves, which after sequencing the "English, Brazilian and South African" variants of the coronavirus, explained Francesco Vaia, medical director of the Institute, has launched a clinical study conducted in tandem with Russian researchers from Gamaleya, who will come to Rome, to evaluate whether Sputnik V will be able to produce antibodies for these strains of the virus as well.
IDEAL VACCINE FOR PEOPLE WITH LOW IMMUNE RESPONSE?
But not only. Spallanzani could also analyze whether the Russian vaccine could be a valid option for vaccinating those who, in particular groups of the population, have a lower immune response. And Vaia also invited Professor Massimo Galli, from the Sacco hospital in Milan, to a "three-way trial".
THE ADVICE OF FARMINDUSTRIA
Farmindustria hopes for a more operational collaboration: "I hope that the EMA will authorize the registration of Sputnik V as soon as possible. We have a continuous dialogue with the Ministry of Economic Development because we want to play a key role in the production of vaccines against Covid, given that Italy is the flagship of the sector in Europe. We see with interest Russia's approach to its production in Italy: on our part there is the utmost openness to collaboration with the Russian government and with the Fund for Direct Investments ", said Marcello Cattani, president of Farmindustria (federation which is part of Confindustria) during the Italian-Russian round table dedicated to Sputnik V.
RDIF BETS ON ITALY
Openings also from the Russian Fund. "Italy is a priority for us, in terms of relations with the European Union: it is the country with which we have a more active dialogue in order to support the recording of Sputnik V", he said, on the occasion of the round table, Vladimir Primak, director of the RDIF, the Russian sovereign wealth fund.
A USEFUL VACCINE
What is certain is that one more weapon, whether or not produced in house, could make the difference in the vaccination campaign. And of this the Italian ambassador to Russia Pasquale Terracciano is well aware, who said: “The health situation in many countries is still difficult but thanks to the large-scale vaccination campaign we are starting to see the light at the end of the tunnel. At this time, to be able to win the battle against Covid, it is necessary to be able to vaccinate as many people as possible in order to fight the emergence of new variants. In this context, it is therefore a priority to guarantee access to vaccines to the entire world population and the common goal, therefore, is to increase the number of vaccines available to people, even within the framework of checks by health certification agencies ".
“I therefore greet the collaboration between Spallanzani and the Gamaleya Institute. It is clear that the vaccine health certification process must not be conditioned by political factors but based solely on verifying the safety and efficacy of the vaccine itself ”.
SPUTNIK: HIGHLY REQUIRED VACCINE
The drug could receive a good reception, even among patients. At least in Lazio: every day "we receive hundreds of requests for the Sputnik vaccine and for this reason we strongly want pragmatism and science to prevail," said the councilor for health of the Lazio Region, Alessio D'Amato, at the round table.
“Timing, speed, are very important in fighting the pandemic. I confirm the desire for a quick check with the Russian Direct Investment Fund regarding the production of the vaccine on the regional territory and I confirm the desire to directly acquire the doses, submitting ourselves to the Italian and European regulatory bodies. We represent an important slice of the Italian and European pharmaceuticals and we believe we must proceed in synergy when the vaccine has obtained all validations ", D'Amato said, informing that" the two AIFA inspectors who will go to Russia to visit the sites have been vaccinated. production of the Sputnik vaccine ”.
SILERI PRO SPUTNIK
"I think that, once the European evaluation standards are exceeded, we need all the vaccines and we need them now, because the first you vaccinate the population and the sooner you get out of this tragedy and it seems to me that at this moment the number of vaccines is not is enough, " he said recently Undersecretary of Health, Pierpaolo Sileri.
GARATTINI: SPUTNIK GOOD VACCINE
Silvio Garattini, founder and president of the Institute of Pharmacological Research Mario Negri Irccs, guest of Cusano Italia Tv, spoke about the vaccine in recent days: "I think that Sputnik is a good vaccine, the published data say that it gives the results of others . This vaccine has a different adenovirus for each dose, the advantage is that after the first administration many antibodies are formed against that virus, so when it does the second with the same virus it risks having less efficiency in cell penetration, while if the second dose does it with a different adenovirus the efficiency is higher ".
THE DOUBTS OF GARATTINI
There is no shortage of doubts, however, on the production front. “The point is that, according to European rules, all drug manufacturers are under constant inspection by the EMA, the Russian ones obviously not, so the EMA has rightly asked for inspections,” explained Garattini. “Russia has joined, but starting from April 26, maybe they have to fix a few things, otherwise they would have said: come tomorrow morning. The vaccine will be produced in Italy because there is a company that has made an agreement, it will be easier to carry out inspections in Caponago rather than in Russia ”.
This is a machine translation from Italian language of a post published on Start Magazine at the URL https://www.startmag.it/sanita/draghi-confindustria-e-spallanzani-non-russano-su-sputnik/ on Tue, 23 Mar 2021 15:36:02 +0000.